[There's millions of'em]

This is irresponsible reporting.
Killing cancer cells in mice is nothing new. Virtually every cancer drug or compound out there did well with testing in mice.
BUT, only a small fraction are able to get approved and pass the initial human trial tests of toxicity before reaching effective dose levels.
Many fail because the liver won’t process them properly.
This product is years away from completing just the Phase1 human trial, if it gets approved for human testing.

There is a drug currently in human trials at the Harvard Cancer complex (Dana Farber Hospital) that has a different MOA from the product hyped in the news releases.
It is Kevetrin, and it is very promising. Several other prominent cancer research hospitals have started or are soon to start additional trials using K with compounds already approved.

[muawiyah]

Two topics ~ eliminating a protective enzyme from cancer cells so that they get et, and increasing the amount of an anti-cancer cell enzyme so that they die.

All pretty simple concepts and will probably be used together to double your doctor bills!

Just hope those macrophages don't carve holes in your gizzard though.

[aimhigh]

Many promising cancer therapies fail because the human testing is done on people who have already been compromised by chemo therapy. The chemo industry is powerful and doesn’t like any competition.